0001578563-24-000387.txt : 20240820
0001578563-24-000387.hdr.sgml : 20240820
20240820181600
ACCESSION NUMBER: 0001578563-24-000387
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240816
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bartholdson John A.
CENTRAL INDEX KEY: 0001382909
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37844
FILM NUMBER: 241226661
MAIL ADDRESS:
STREET 1: C/O STONINGTON PARTNERS, INC.
STREET 2: 540 MADISON AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioventus Inc.
CENTRAL INDEX KEY: 0001665988
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 810980861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 474-6700
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
wk-form4_1724192154.xml
FORM 4
X0508
4
2024-08-16
0
0001665988
Bioventus Inc.
BVS
0001382909
Bartholdson John A.
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM
NC
27703
1
0
1
0
0
Class A Common Stock
2024-08-16
4
P
0
80000
8.5467
A
6913857
I
See Footnotes
Class A Common Stock
2024-08-19
4
P
0
25500
8.5477
A
6939357
I
See Footnotes
Class A Common Stock
45552
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.33 to $8.65, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Consists of (i) 4,624,431 shares of Class A Common Stock held by Juniper Targeted Opportunity Fund, L.P. ("Juniper Fund"), (ii) 2,239,076 shares of Class A Common Stock held by Juniper Targeted Opportunities, L.P. ("Juniper Targeted Opportunities"), on an aggregate basis following all transactions reported herein, and (iii) 75,850 shares of Class A Common Stock held by Juniper Multi-Strategy Fund, L.P. ("Juniper Multi-Strategy" and, together with Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, the "Juniper Entities").
Juniper HF Investors II, LLC ("Juniper HF II"), Juniper Targeted Opportunity Investors, LLC ("Juniper TO") and Juniper HF Investors, LLC ("Juniper HF") are each the general partner of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, respectively. Juniper Investment Company, LLC ("Juniper Investment Company") provides investment advisory and management services and acts as the investment manager of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy. The Reporting Person is a managing member of Juniper Investment Company, Juniper HF II, Juniper TO and Juniper HF and shares voting and dispositive power with respect to the shares held by the Juniper Entities. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.52 to $8.55, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ Anthony D'Adamio, Attorney-in-Fact
2024-08-20